DigiPath Labs Enables Opening of First Marijuana Dispensary in Las Vegas

http://www.prnewswire.com/news-releases/digipath-labs-enables-opening-of-first-marijuana-dispensary-in-las-vegas-300130454.html


LAS VEGAS, Aug. 19, 2015 /PRNewswire/ -- DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), has cleared the way for the opening of the first cannabis dispensary in Southern Nevada.

The state-of-the-art cannabis testing facility performed extensive quality assurance testing on the first batch of cannabis harvested by Alternative Medicine Association and approved it for medical use. The green light from DigiPath Labs should expedite the opening of Euphoria Wellness, which plans to open in Las Vegas soon, and is exciting news for patients who eagerly await access to safe, reliable medicinal cannabis.

"This is a huge milestone for patients in Las Vegas and the rest of Southern Nevada," explains Todd Denkin,
DigiPath Labs' CEO. "We have been gearing up for this day for well over
a year, and we are staffed and equipped to be able to provide cannabis
testing services for not only the region, but the entire state."


\t\t\t\t\t \t\t\t\t\t \t\t\t \t\t \t \t\t \t\t\t \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t The opening of cannabis dispensaries in Nevada was 15 years in the making. Although Nevada
began allowing medical marijuana use in 2001, it only permitted
attending physicians to recommend the use of cannabis for patients and
extended legal protection for patients to grow up to 12 plants and
possess up to 2.5 ounces of cannabis in a single 14-day period.


\t\t\t\t\t \t\t\t\t\t \t\t\t \t\t \t \t\t \t\t\t \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t In April 2014,
Senate Bill 374 expanded patient access by establishing a statewide
medical cannabis distribution program, which allows up to 66
dispensaries and 200 production facilities to operate in the Silver
State. The program was designed and is regulated by the Department of
Health and Human Services.


\t\t\t\t\t \t\t\t\t\t \t\t\t \t\t \t \t\t \t\t\t \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t Nevada Medical Marijuana Association Executive Director Will Adler was recently quoted by the Las Vegas Sun
as stating that the state's strict rules are designed to prevent
problems and become "the gold standard for the country." The rules
include seed-to-sale tracking systems and testing processes that measure
product potency and help screen out products that contain hundreds of
potentially harmful contaminants, including pesticides and mold.


\t\t\t\t\t \t\t\t\t\t \t\t\t \t\t \t \t\t \t\t\t \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t "Standards are seamlessly integrated into our lives-and for very good reasons," says Dr. Cindy Orser, DigiPath Labs' Chief Science Officer. "When you take a 350 mg aspirin,
you can be confident it won't contain 600 mg or might not contain any
aspirin at all. You don't have to worry it might contain mercury,
pesticides, or mold. We need that kind of reliability in marijuana
products, especially those intended for patients."


\t\t\t\t\t \t\t\t\t\t \t\t\t \t\t \t \t\t \t\t\t \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t Dr.Orser is routinely called upon to deliver expert testimony on cannabis
testing, which helps lawmakers and law enforcement understand the
importance of cannabis testing and adopting rigorous standards. Dr.
Orser recently spoke about the importance of standards in medical
cannabis testing at the Conference of Western Attorneys General (CWAG).

For more information about DigiPath Labs, go to http://digipathlabs.com.
About DigiPath, Inc. (OTCQB: DIGP) DigiPath,Inc., supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news
coverage to the nation. DigiPath's three business units are DigiPath
Labs, TNM News Corp., and DigiPath Corp. For more information about
DigiPath Labs, go to http://digipath.com.

\t\t\t\t\t \t\t\t\t\t \t\t\t \t\t \t \t\t \t\t\t \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t Information about Forward-Looking Statements


\t\t\t\t\t \t\t\t\t\t \t\t\t \t\t \t \t\t \t\t\t \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t This press release contains "forward-looking statements" that include
information relating to future events. Forward-looking statements are
based on information available at the time they are made, and are
subject to risks and uncertainties that could cause actual performance
to differ materially from those stated. For a description of the risk
factors and uncertainties affecting DigiPath, please refer to the
Company's recent Securities and Exchange Commission filings, which are
available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements.


\t\t\t\t\t \t\t\t\t\t \t\t\t \t\t \t \t\t \t\t\t \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t Contact:
DigiPath, Inc.
info@digipath.com
702.533.6884